Illumina, Inc. (NASDAQ:ILMN) announced today that it ... lowered the firm’s price target on Illumina (ILMN) to $100 from $170 and keeps a Buy rating on the shares. The stock has fallen ...

(NASDAQ:ILMN) for five years would be nursing their metaphorical wounds since the share price dropped 75% in that time. And we doubt long term believers are the only worried holders, since the stock ...

Shares of genomics company Illumina (NASDAQ:ILMN) fell 8.6% in the morning ... on the minds of investors. The stock market ...

Momentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook ... and consumer ...

If an investor was to purchase shares of ILMN stock at the current price level ... last 250 trading day closing values as well as today's price of $77.24) to be 42%. For more put and call options ...

If an investor was to purchase shares of ILMN stock at the current price level ... last 250 trading day closing values as well as today's price of $82.61) to be 40%. For more put and call options ...

In a report released yesterday, Puneet Souda from Leerink Partners maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...

Illumina (NASDAQ:ILMN – Get Free Report) had its price objective decreased by stock analysts at Citigroup ... genomic regions of interest. Receive News & Ratings for Illumina Daily - Enter ...

Grail cutting-edge cancer blood test has stirred investor excitement many times in the past few years. With the stock down 55% from its February peak, Canaccord Genuity issued a Buy recommendation on ...